Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures

Contrast-induced nephropathy (CIN) is a frequent and severe complication in subjects receiving iodinated contrast media for diagnostic or therapeutic purposes. Several preventive strategies were evaluated in the past. Recent clinical studies and meta-analyses delivered some new aspects on preventive...

Descripción completa

Detalles Bibliográficos
Autores principales: Patschan, D., Buschmann, I., Ritter, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954945/
https://www.ncbi.nlm.nih.gov/pubmed/29854458
http://dx.doi.org/10.1155/2018/5727309
_version_ 1783323621644566528
author Patschan, D.
Buschmann, I.
Ritter, O.
author_facet Patschan, D.
Buschmann, I.
Ritter, O.
author_sort Patschan, D.
collection PubMed
description Contrast-induced nephropathy (CIN) is a frequent and severe complication in subjects receiving iodinated contrast media for diagnostic or therapeutic purposes. Several preventive strategies were evaluated in the past. Recent clinical studies and meta-analyses delivered some new aspects on preventive measures used in the past and present. We will discuss all pharmacological and nonpharmacological procedures. Finally, we will suggest individualized recommendations for CIN prevention.
format Online
Article
Text
id pubmed-5954945
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-59549452018-05-31 Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures Patschan, D. Buschmann, I. Ritter, O. Int J Nephrol Review Article Contrast-induced nephropathy (CIN) is a frequent and severe complication in subjects receiving iodinated contrast media for diagnostic or therapeutic purposes. Several preventive strategies were evaluated in the past. Recent clinical studies and meta-analyses delivered some new aspects on preventive measures used in the past and present. We will discuss all pharmacological and nonpharmacological procedures. Finally, we will suggest individualized recommendations for CIN prevention. Hindawi 2018-05-02 /pmc/articles/PMC5954945/ /pubmed/29854458 http://dx.doi.org/10.1155/2018/5727309 Text en Copyright © 2018 D. Patschan et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Patschan, D.
Buschmann, I.
Ritter, O.
Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures
title Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures
title_full Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures
title_fullStr Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures
title_full_unstemmed Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures
title_short Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures
title_sort contrast-induced nephropathy: update on the use of crystalloids and pharmacological measures
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954945/
https://www.ncbi.nlm.nih.gov/pubmed/29854458
http://dx.doi.org/10.1155/2018/5727309
work_keys_str_mv AT patschand contrastinducednephropathyupdateontheuseofcrystalloidsandpharmacologicalmeasures
AT buschmanni contrastinducednephropathyupdateontheuseofcrystalloidsandpharmacologicalmeasures
AT rittero contrastinducednephropathyupdateontheuseofcrystalloidsandpharmacologicalmeasures

Ejemplares similares